Keystone Financial Group - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 61 filers reported holding LEAP THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Keystone Financial Group ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$7,704
-48.6%
17,1200.0%0.00%
-33.3%
Q3 2022$15,000
-25.0%
17,1200.0%0.00%
-25.0%
Q2 2022$20,000
-33.3%
17,1200.0%0.00%
-20.0%
Q1 2022$30,000
-45.5%
17,1200.0%0.01%
-44.4%
Q4 2021$55,000
-20.3%
17,1200.0%0.01%
-25.0%
Q3 2021$69,00017,1200.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders